aid: citryll

name: Citryll

description: 'Citryll is a biotech company developing CIT-013, a first‑in‑class monoclonal antibody targeting Neutrophil Extracellular Traps (NETs) to treat immune‑mediated inflammatory diseases such as rheumatoid arthritis and hidradenitis suppurativa. The company focuses on innovative therapies addressing the underlying biology of inflammation.'

url: https://raw.githubusercontent.com/api-evangelist/citryll/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-08 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-08'

modified: '2026-10-08'

tags:
- Company
- Biotechnology
- Immunology
- Therapeutics
- ClinicalTrials
- Biopharma

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: LLMsTxt
  url: llms/citryll-llms.txt
- type: Hosts
  url: hosts/citryll-hosts.yml
- type: TermsOfService
  url: https://citryll.com/terms-conditions/
- type: PrivacyPolicy
  url: https://citryll.com/privacy-policy/
- type: DomainSecurity
  url: security/citryll-domain-security.yml
- type: Website
  url: https://citryll.com

apis: []

x-coverage:
  state: unreadable
  reason: js-rendered-docs
  detail: The Citryll website renders its documentation via JavaScript, preventing retrieval of a machine‑readable OpenAPI spec.
  evidence:
    - url: https://citryll.com
      status: 200
  checked: '2026-10-08'
x-enrichment:
  date: '2026-10-08'
  status: enriched
  artifacts_added: 7
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local